Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Mad2 who wrote (2528)	4/20/2000 9:41:00 AM
From: Hank	Respond to of 5582

Mad, Don't you know by now that ALL press releases from GUMM are good news? Especially if you ask the Magic Eight Ball (aka Danny "The Shill").

To: Mad2 who wrote (2528)	4/20/2000 9:57:00 AM
From: Mike M	Read Replies (2) \| Respond to of 5582

What you say is true were one to buy your assumptions. (i.e.) Is this a one product company? Have the sales peaked? Will the Zicam knock offs be able to stunt growth and will competition become fierce? This has always been the point of contention. First round went to the bulls. Second round to the bears. I think today's decision has far reaching implication and that should become apparent in the near future. Next year's results will be critical to answering the questions you raise regarding Zicam. Next year will also answer the question about this being a one product company. I think the answer will surprise many. Given this, I still fail to see the comparison with QGLY.